Cargando…
The clinical impact of IKZF1 mutation in acute myeloid leukemia
Genetic heterogeneity poses a great challenge to the understanding and management of acute myeloid leukemia (AML). Knowledge of the IKZF1 mutation in AML specifically is extremely limited. In a previous work, we described the distribution pattern of IKZF1 mutation in AML, but its clinical impact has...
Autores principales: | Zhang, Xiang, Huang, Aijie, Liu, Lixia, Qin, Jiayue, Wang, Chengcheng, Yang, Min, Lou, Yinjun, Wang, Lei, Ni, Xiong, Hu, Xiaoxia, Tang, Gusheng, Zhang, Mengmeng, Cao, Shanbo, Mao, Liping, Qian, Jiejin, Xu, Weilai, Wei, Juying, Xu, Gaixiang, Meng, Haitao, Mai, Wenyuan, Yang, Chunmei, Zhu, Honghu, Tong, Hongyan, Yang, Jianmin, Yu, Wenjuan, Wang, Jianmin, Jin, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061890/ https://www.ncbi.nlm.nih.gov/pubmed/36997950 http://dx.doi.org/10.1186/s40164-023-00398-y |
Ejemplares similares
-
A clinical prediction model identifies a subgroup with inferior survival within intermediate risk acute myeloid leukemia
por: Hu, Xiaoxia, et al.
Publicado: (2021) -
A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients
por: Yang, Min, et al.
Publicado: (2022) -
Clinical and Genetic Characteristics of IKZF1 Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia
por: Zhang, Jingying, et al.
Publicado: (2022) -
P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL
por: Wang, Huafeng, et al.
Publicado: (2023) -
First case report of a NUP98-PMX1 rearrangement in de novo acute myeloid leukemia and literature review
por: Fu, Weijia, et al.
Publicado: (2021)